VRS
CTMX icon

Virginia Retirement Systems’s CytomX Therapeutics CTMX Stock Holding History

Virginia Retirement Systems’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150,300
Closed -$765K – 1111
2021
Q3 		$765K Buy
150,300
+32,600
+28% +$175K 0.01% 690
2021
Q2 		$745K Sell
117,700
-13,400
-10% -$104K 0.01% 743
2021
Q1 		$1.01M Buy
131,100
+103,300
+372% +$818K 0.01% 656
2020
Q4 		$182K Buy
+27,800
New +$199K ﹤0.01% 1067

Other funds holding CTMX

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virginia Retirement Systems's CTMX Position: Q4 2021 in Review

Virginia Retirement Systems sold out of CytomX Therapeutics (CTMX) in Q4 2021, closing a stake of 150,300 shares — an estimated $765K sold.

Virginia Retirement Systems first reported a position in CTMX in Q4 2020 and held it in 4 quarters. The position peaked at $1.01M in Q1 2021. 110 funds tracked by Wall St. Rank hold CTMX as of Q4 2021.

  • Virginia Retirement Systems reported no remaining CytomX Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 150,300 CytomX Therapeutics shares in Q4 2021, an estimated $765K.
  • Virginia Retirement Systems first reported a position in CytomX Therapeutics in Q4 2020 and held it in 4 quarters.
  • Virginia Retirement Systems's CytomX Therapeutics position peaked at $1.01M in Q1 2021.
  • 110 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q4 2021.

Based on Virginia Retirement Systems's 13F filing for Q4 2021, filed 3 Feb 2022.